Major outcomes of patients who received DLIs
| Characteristic . | No. . |
|---|---|
| Alive/dead | 47/34 |
| Graft hypoplasia | 9 |
| Range of onset after first DLI, d | 42-294 |
| Acute GVHD | 27 (33%) |
| Grade I | 4 |
| Grade II-IV | 23 (28%) |
| Grade III-IV | 12 (15%) |
| Organs affected | |
| Skin | 21 |
| Gut | 11 |
| Liver | 7 |
| Chronic GVHD | 23/69 (33%) |
| Limited | 5 |
| Extensive | 18 |
| Organs affected | |
| Skin | 13 |
| Gut | 8 |
| Liver | 13 |
| Mouth | 5 |
| Eyes | 3 |
| Antecedent acute GVHD | 14 |
| Clinical response | 23/51 (45%) |
| Complete | 18 |
| Partial | 5 |
| Remained in CR | 13 |
| Chimerism response | 25/55 (45%) |
| Complete | 19 |
| Partial | 6 |
| Remained 100% donor | 8 |
| Characteristic . | No. . |
|---|---|
| Alive/dead | 47/34 |
| Graft hypoplasia | 9 |
| Range of onset after first DLI, d | 42-294 |
| Acute GVHD | 27 (33%) |
| Grade I | 4 |
| Grade II-IV | 23 (28%) |
| Grade III-IV | 12 (15%) |
| Organs affected | |
| Skin | 21 |
| Gut | 11 |
| Liver | 7 |
| Chronic GVHD | 23/69 (33%) |
| Limited | 5 |
| Extensive | 18 |
| Organs affected | |
| Skin | 13 |
| Gut | 8 |
| Liver | 13 |
| Mouth | 5 |
| Eyes | 3 |
| Antecedent acute GVHD | 14 |
| Clinical response | 23/51 (45%) |
| Complete | 18 |
| Partial | 5 |
| Remained in CR | 13 |
| Chimerism response | 25/55 (45%) |
| Complete | 19 |
| Partial | 6 |
| Remained 100% donor | 8 |